Atara Biotherapeutics, Inc. Annual Depreciation in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2023.
  • Atara Biotherapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $700K, a 22.2% decline year-over-year.
  • Atara Biotherapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $3.5M, a 2.78% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Depreciation for 2023 was $3.7M, a 21.3% decline from 2022.
  • Atara Biotherapeutics, Inc. annual Depreciation for 2022 was $4.7M.
  • Atara Biotherapeutics, Inc. annual Depreciation for 2016 was $383K, a 698% increase from 2015.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.7M -$1M -21.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $4.7M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2016 $383K +$335K +698% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-09
2015 $48K +$42K +700% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-09
2014 $6K +$2K +50% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $4K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.